Enerceptan (etanercept biosimilar) / AMEGA Biotech  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Enerceptan (etanercept biosimilar) / AMEGA Biotech
GEMENE, NCT03332719: Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis

Completed
3
168
RoW
Etanercept, Methotrexate
Gema Biotech S.A., QUID Quality in Drugs and Devices Latin American Consulting SRL
Rheumatoid Arthritis
03/17
09/17
GEMENE002, NCT03403140: Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( )

Unknown status
3
141
RoW
Etanercept
Gema Biotech S.A., QUID Quality in Drugs and Devices Latin American Consulting SRL
Rheumatoid Arthritis
09/18
10/18

Download Options